Research Article
High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma
Table 2
Univariate and multivariate Cox proportional risk regression analyses of E2F4.
| Characteristics | Total () | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Age | 327 | 1.306 (0.943-1.808) | 0.108 | 1.299 (0.918-1.838) | 0.139 | ≤60 | 155 | | | | | >60 | 172 | | | | | Gender | 328 | 1.112 (0.793-1.559) | 0.540 | 1.030 (0.719-1.477) | 0.871 | Male | 226 | | | | | Female | 102 | | | | | Clinical stage | 318 | 1.272 (0.882-1.834) | 0.198 | 1.239 (0.849-1.807) | 0.267 | Stage I-II | 90 | | | | | Stage III-IV | 228 | | | | | Histologic grade | 320 | 1.264 (0.869-1.837) | 0.220 | 1.214 (0.831-1.773) | 0.315 | G1-2 | 251 | | | | | G3-4 | 69 | | | | | E2F4 | 328 | 1.405 (1.017-1.941) | 0.039 | 1.384 (0.993-1.929) | 0.048 | Low | 164 | | | | | High | 164 | | | | |
|
|